Three Questions

Three Questions: Matt Kibby, BBK Worldwide

Monday, March 20, 2017

CWWeekly presents this biweekly feature as a spotlight on issues that executives in clinical research face. This week, writer Sony Salzman spoke with Matt Kibby, president of BBK Worldwide. Matt leads BBK’s technology group, which develops and integrates the company’s patient recruitment data systems to optimize studies for sponsors and CROs globally.

[Read More]

Three Questions: Dr. Martin Gibson, NorthWest EHealth

Monday, March 6, 2017

CWWeekly presents this biweekly feature as a spotlight on issues that executives in clinical research face. This week, writer Suz Redfearn spoke with Dr. Martin Gibson, chief executive of the U.K.’s NorthWest EHealth, which develops links between academia and the U.K.’s National Health System in health informatics and the use of electronic patient records to support research. Dr. Gibson helped develop the Salford Lung Studies, two recent GSK-sponsored trials that substituted EHR for regular patient visits.

[Read More]

Three Questions: Dawn M. Furey, Merck & Co.

Tuesday, February 21, 2017

CWWeekly presents this feature as a spotlight on issues faced by executives in clinical research. This week, writer Barbara M. Bolten spoke with Dawn M. Furey, executive director, head of Global Operations, Global Clinical Trial Operations, Merck & Co. Furey leads the global alignment of strategies for implementation of clinical trial operations with a focus on trial feasibility and allocation, trial site documentation, enrollment/retention planning and support of project delivery. She also led the implementation of a cloud-based electronic trial master file solution, Veeva Vault eTMF.

[Read More]

Three Questions: Jeff Pohlig, Compass Research

Monday, February 6, 2017

CWWeekly presents this feature as a spotlight on issues faced by executives in clinical research. This week, writer Karyn Korieth spoke with Jeff Pohlig, vice president, U.S. Operations for Compass Research, which is part of the Bioclinica Research Network. Compass Research, which has three locations in Central Florida, was a finalist for the Society for Clinical Research Sites’ 2016 Site Patient Recruitment Innovation Award (SPRIA), which recognizes research sites that have developed and implemented innovative patient recruitment programs.

[Read More]

Three Questions: Mohammad A. Millwala, DM Clinical Research

Monday, January 23, 2017

CWWeekly presents this feature as a spotlight on issues faced by executives in clinical research. This week, writer Karyn Korieth spoke with Mohammad A. Millwala, CEO of DM Clinical Research, a network of investigative sites based out of Tomball, Texas. DM Clinical Research was a finalist for the Society for Clinical Research Sites’ 2016 Site Patient Recruitment Innovation Award (SPRIA), which recognizes research sites that have developed and implemented innovative patient recruitment programs.

[Read More]

Three Questions: Mary Schmoll, American Health Network of Indiana

Monday, January 9, 2017

CWWeekly presents this feature as a spotlight on issues faced by executives in clinical research. This week, writer Karyn Korieth spoke with Mary Schmoll, director of clinical research at the American Health Network of Indiana (AHNI), which offers clinical research at seven investigative sites in Indiana. AHNI’s Research Department won the Society for Clinical Research Sites’ 2016 Site Patient Recruitment Innovation Award (SPRIA), which recognizes research sites that have developed and implemented innovative patient recruitment programs.

[Read More]

Three Questions: Irina Petrova, M.D., OCT

Monday, December 12, 2016

CWWeekly presents this feature as a spotlight on issues faced by executives in clinical research. This week, writer Karyn Korieth spoke with Irina Petrova, M.D., director of Clinical Operations at OCT, a full-service CRO based in Russia that also operates in Europe and the U.S.

[Read More]

Three Questions: Dr. Stella Blackburn, QuintilesIMS

Monday, November 28, 2016

CWWeekly presents this biweekly feature as a spotlight on issues that executives in clinical research face. This week, writer Suz Redfearn spoke with Dr. Stella Blackburn, vice president and global head of risk management for real-world evidence solutions at QuintilesIMS. As part of her efforts, Blackburn has been focused on the EMA’s adaptive pathways pilot program.

[Read More]